Rasilamlo
Active substance: aliskiren, amlodipine
aliskiren, amlodipine
Centralised EU authorisationWithdrawn
Marketing holder: Novartis Europharm Ltd
Verified 2026-10-09 · EMA
- Source: EMA
- Countries with the substance registered: 1
Composition
Registration
- Registration number
- EMEA/H/C/002073
- Registration status
- Withdrawn
- ATC code
- C09XA53
Sources
- product · EMA · EMEA/H/C/002073 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/002073 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/002073 · Verified 2026-10-09
- ingredients.1 · EMA · EMEA/H/C/002073 · Verified 2026-10-09